BANK VONTOBEL/CALL/CVS HEALTH/88/0.1/20.12.24 Share Price

Warrant

DE000VD3SQR5

Market Closed - Bid/Ask 11:25:37 26/06/2024 pm IST Pre-market 11:33:02 am
0.025 EUR -7.41% Intraday chart for BANK VONTOBEL/CALL/CVS HEALTH/88/0.1/20.12.24 0.03 +20.00%
1 month+47.06%
Date Price Change
26/24/26 0.025 -7.41%
25/24/25 0.027 -12.90%
24/24/24 0.031 0.00%
21/24/21 0.031 -3.13%
20/24/20 0.032 -3.03%

Real-time Boerse Frankfurt Warrants

Last update June 26, 2024 at 11:25 pm IST

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying CVS HEALTH CORPORATION
IssuerLogo Issuer Vontobel Vontobel
WKN VD3SQR
ISINDE000VD3SQR5
Date issued 09/04/2024
Strike 88 $
Maturity 20/12/2024 (177 Days)
Parity 10 : 1
Emission price 0.18
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.156
Lowest since issue 0.014
Spread 0.01
Spread %28.57%

Company Profile

CVS Health Corporation is one of the leading American suppliers of health products and services. Net sales (including intragroup) break down by activity as follows: - medical insurance plan management services (45.6%; Pharmacy Benefit Management): administrative management (reimbursement management, patient claim processing, etc.), drug distribution, decision-making information, sales of medical information management services, etc.; - retail distribution (28.5%): sale of prescription pharmaceutical products, OTC products, beauty and cosmetics products. At the end of 2023, products are marketed primarily via a network of more than 9,000 outlets and via the Internet. In addition, the group offers healthcare services through more than 1,000 clinics (MinuteClinic®); - medical benefits management (25.8%); - other (0.1%).
Sector
-
More about the company

Ratings for CVS Health Corporation

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: CVS Health Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
28
Last Close Price
60.63 USD
Average target price
69.1 USD
Spread / Average Target
+13.96%
Consensus